ERBB2 and non-small cell lung carcinoma: According to the GO analysis, the most vital biological processes involved in the anti-NSCLC activity of 18α-GA were attributed to the ERBB2 signaling pathway, signal transduction, PI-mediated signaling, cell proliferation, negative regulation of apoptosis, regulation of phosphatidylinositol 3-kinase (PI3K) mediated signaling and peptidyl-tyrosine phosphorylation among others.